OKYO Pharma Ltd (OKYO) FinancialsOKYOFinancialOKYO Pharma Ltd

In the context of the broader market, OKYO competes directly with industry leaders such as KLRS and RLYB. With a market capitalization of $87.64M, it holds a significant position in the sector. When comparing efficiency, OKYO's gross margin of N/A stands against KLRS's N/A and RLYB's 100.00%. Such benchmarking helps identify whether OKYO Pharma Ltd is trading at a premium or discount relative to its financial performance.

The company has a negative P/E ratio of -6.26 and a price-to-sales ratio of 0, indicating it is not generating revenue relative to its market cap, which is concerning for long-term viability.